| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO
1 company
Blum Robert I is a President &CEO at CYTK. Recent filings cover 0 purchases and 135 sales. Those positions are worth an estimated $30.7M at current prices.
Our model assigns Blum Robert I a middling insider score of 50/100, based on 99 past trades. Over a 12-month horizon, 33.0% of those trades were profitable, with an average 12-month return of -30.9%.
Blum Robert I's largest disclosed position is in CYTK as President &CEO, worth about $30.7M. The recent filings there lean toward selling, a net 1,100,105 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2020 | CYTK Cytokinetics Inc | President &CEO | Sale+OE | 5,000 | $24.85 | $124,255.00 | -1.6% | |
| Jun 24, 2020 | CYTK Cytokinetics Inc | President &CEO | Sale+OE | 5,000 | $23.86 | $119,308.50 | -0.8% | |
| Jun 11, 2020 | CYTK Cytokinetics Inc | President &CEO | Sale+OE | 5,000 | $21.47 | $107,353.50 | -1.6% | |
| May 29, 2020 | CYTK Cytokinetics Inc | President &CEO | Sale+OE | 5,000 | $20.10 | $100,503.00 | -1.6% | |
| May 18, 2020 | CYTK Cytokinetics Inc | President &CEO | Sale+OE | 5,000 | $22.15 | $110,732.49 | -0.8% |